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TWIN STUDIES AND OTHER GENETICAL INVESTIGATIONS IN
THE DANISH CANCER REGISTRY.
T. BUSK, J. CLEMMESENAND A. NIELSEN.
From the Dani8h Cancer Regi8try under The National Anti-Cancer
League, Copenhagen.
Given at the Symposium on the Genetics of Cancer, Londoni June 24 and 25, 1948.
THF, Danish Cancer Registry, founded in 1942 by the National Anti-Cancer
League, and working in close collaboration with the National Health Service,
is an organization with the primary intention to register all cancer cases, for
resbarch purposes. This is done through a voluntary system ; all hospitals
noti.y their cancer cases to the registry, and these notifications are supplemented
with death certificates for all persons who are known to have suffered from
malignant diseases, including leukaemias, myelomata and brain tumours.
From Clemmesen's studies onoccupationalmortality from cancer in Denmark
it wasclear,alreadybefore the start oftheRegistry, that acompleteinvestigation
of the occurrence of cancer demAnded at least an estimation of the role played
by heredity in the origin of various cancers. It -was thought to be especially
valuable to carry out such an investigation alongside the mapping out of cancer
incidence withregard to age, occupation, and othervariables, and to compare the
hereditarytendency shownby cancers ofvarious sites in the samepopulation and
at the same time.
So collaboration was established with'Professor Kemp's Institute for Human
Genetics supported by mutual grants. Dr. Jacobsen (surgeon) investigated
the heredity of breast cancer, and Dr. Videbaek (physician) studied leukaemia,
in collaboration with the Institute for Pathological Anatomy. Dr. Brobech
(radiologist) compared the heredity of cervical and body cancers of the uterus,
and Dr. Feilberg (s'urgeon) is analysing the genetical basis of multiple cancers.
The financialsupport isgivenbygrants fromKing Christian X Fund.
We believe that the results so far obtained have been more encouraging from
anoncologicalthan from ageneticalpoint ofview. While the methodsemployed
have made it possible to show a practically demonstrable hereditary tendency
to breast cancer, followed by a tendency to cancers of all sites, and while
leukaemia and cancers of all sites show similar features, the mode of inheritance
is difficult to work out, because of the less reliable information obtainable from
relatives more remote than sisters, brothers or parents of the patients.
An efficient examination ofthe mode ofinheritance could no ddubt be carried
out by means of a registration system for cancer patients covering a few genera-
tions. So far our registration system has not been made complete, but in order
to exploit fully the opportunities at hand we have examined-as a link in the
system ofgeneticalinvestigations-the occurrence of cancer in twins among the
cancer cases notified from Danish hospitals in the first six years of theregistry,
1942-1947, realising that an unselected sample of such cases would be of some
interest.157 TWIN STUDlES
IHEREDITY IN BREAST CANCER AND LEUKAEMIA.
Jacobsen, inhismonographHeredity in Breast Cancer,examinedthe occurrence
of cancer in the familes of 200 breast cancer cases from the files of the Cancer
Registry, and compared them with 200 control families (Table 1).
TABLIF, I.-Jacob8en's Brea8t Cancer and Control Propositae. Observed and
Computed Number of Cancer Cases among Relatives.
(200 breast cancer cases.)
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Nearly all cancer cases among the relatives were checked by means of case-
records from hospitals or death certificates. This applies,without exception to
the nearer relatives, and both to test and control material. As -there was some
doubt as to the absolutevalidity ofthis controlmethod, wecomputed the number
of cancer cases which would beexpected, based on the morbidity figures from the
Cancer Registry and on the official mortality statistics. The data of Table I
show that the value ofJacobsen's control material is rather doubtful withregard
to the groups of more remote relatives. For the groups of closer relatives, as
parents andsibs,however, it isfullyjustified to draw conclusionsw'ithregard both
to breast cancer and to cancerof all sites, both of which show -a definite excess
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Videbaek, working on cases with leukaemia (Table II), made a careful collec-
tion ofcontrol material. It is clear from ouranalysis that he succeeded to some
extento'nly ; but the data show that there, is still a significant excess of cancer
among fathers and sisters of leukaemiapatients.
r ABLE II.-VI, ebaek'8Leukaemia and Control Propo8iti. Observed an
Coitiputed Number of Cancer Death8among Relatives.
(209 leukaemia cases.)
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t ---,%
Obs. Comp. 1. Comp. 11.
Control propositi.
r- -k.. ----I
Obs. Comp. Obs./comp.
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Theseinvestigationsinto theheredity ofbreast cancerandleukaemiaiBustrate
that even under very favourable conditions which prevail in a small country,
and with easy access to families interested in such investigations, it is very Giffi-
cult indeed to obtain a satisfactory control materia'l. Nevertheless, the data
so far obtained show that there is a definitehereditarytendency to breast cancer,
combined with atendency to cancers ofallsites, and acorrespondingphenomenon
was found withregard toleukaemia and cancers ofallsites.
It has been reported by various authors that in families with a hereditary
predisposition for cancer, the disease will appear at an earlier age in the younger
generations. Thus Videbaek found an
" anticipation
" in materialgathered from
tbe literature, but it can be demonstrated 'on' his own material as well as onTWIN STUDIES 159
Jacobsen'sthat ahigherage ofthepropositus was followedby alossin'thenumber
of known grandparents, which indicates reduced reliability of even family
inforination from older propoaiti. Moreover, the younger generation will
show a higher number of diagnosed cancers and leukaemias as a consequence
of the development ofdiagnostic facilities. The difference in age at onset of
the disease in differentgenerations may, therefore,be due to the method ofobser-
vation itself, as is shown by the fact that leukaemia and cancer cases observed
at about the same time but in different generations will exhibit age differences.
Jacobsen observed that propositae among whose relatives he found cases of
cancerwereyounger thanpropositae with families without can'cer,andheassumed
that this was due to hereditary factors. Another explanation, however, seems
to be more obvious, viz. that the old propositae are unable to give detailed
information about their' relatives in earlier generations becauseAhese relatives
most often died years ago. This assumption is supported by the fact that most
ofthe oldpropositae aregroupedbyJacobsenamongst those with
" nohereditary
predisposition."
We find it very doubtful whether anticipation and an earlier occurrence of
hereditarilypr'edisposed cance'r cases can be demonstrated by means ofmaterials
collected -as those published by Jacobsen and Videbaek. Material collected in a
registrydoesnot seemto havethe sameshortcomings,but afurtherandpresumably
final study of such phenomena would, however, demand a cancer registration
through a longer period, and at present this has not been achieved anywhere.
Yet, our material seems to offer agoodopportunity for studies on can'cer in twins
(and already from the start of the genetical team-work such an investigation
had been prepared).
HEREDITY OF CANCER IN TWIENS.
It seemspartl'cularlyadvantageous that we have at ourdisposal an unselected
material which is. rather unusual for twin studies of this kind. It coniprised.
griginallyallhospital cancer casesfromthe Danishpopulationof4millionthrough
six years, or an annual -number between 5000 and 6000 cases, but this figure
must be reduced by about 20 per cent in which the questio'n about twin birth
had been left unanswered, giving a total very near to 30,000 cases (29,458).
The system of notification involves a rather heavy toll of omissions, vet it
has functioned satisfactorily. The special questions asked twins with cancer-
besides such items as name, address, 'Occupation and the like-were confinea to
previous diseases of a more serious character, including diagnosis and the date,
and place of treatment. In order to identify whether the twins were mollo-
zygotic ordizygotic, questions were asked about thesimilarityand aboutmistakes
made by parents or others, and similarly about type and colour of hair, colour
of eyes, stature, height and weight
- On the whole it may be said that we
demanded almost full congruity before accepting a pair as monozygotic. The
final distribution of dizygotic twins on groups of same and opposite sex,
and the proportion between monozygotic and dizygotic pairs seem to show that
our measures have been justified. It should be stressed that we have not been
in-a position to contact the patients or their twins personally. We have had to
rely on information from the hospital doctors, and, on thewhole, our confidence
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however,hadto be discarded as a result ofspecialinquiries to hospitals aboutthe
cases. Out of a total ofabout 30,000 hospital cases notified for cancer we found
315 pairs of twins, or 1-07 per cent. The official percentage of twin births in
Denmark for the years 1926-30 is 1-64, and considering the increased mortality
among twin babies we'think this a satisfactory correspondence.
Another check on the result was obtainedthroughcomputation of the number
of deaths expected from all causes among twins for whom notifications were
satisfactory. Among monozygotic twins we expected 20,8 deaths against 16
observed. Among dizygotics we expected 36-3 and found 26. These differences
arenotstatistically'significant, and they may be partially due to thelessefficient
information about those pairs of which one partner has died. In Denmark, as
elsewhere, the girl-boy ratio at birth is 0,97 with a male excess, which in the
course of a fev years changes to a slight female preponderance. However, we
find among both monozygotic pairs and dizygotic pairs ofopposite sex a female
preponderanceof 1,48to 1, and 1,64 among the same-sexeddizygoticpairs,making
1'53 for the total. The explanation of this considerable female excess m our
material no doubt must beascribed to the higher cancer incidence among females
than among males in Denmark, combined with the earlier age -in which female
cancers arise. And, if we calculate the percentage ofopposite-sexed twin pairs
in ourmaterial, afigurewhichshouldbeuninfluencedbythedifferenceinmortality
among the two sexes, we find exactly the same value as in the corresponding
officialbirth statistics-36,2 per cent.
In spite ofthese satisfactory results, it should be remembered that in dealing
withtwin-pairs, ofwhich at least one issuffering fromold-age disease like cancer,
we must expect insufficient information from twins in cases where the partner
died in childhood. Therefore we have excluded thetwin-pairs where onepartner bas died before the age of 5 years. Similarly we have lost sight of a number of
cc second
" twins through emigration and similar events, so that the number has
shrunk'from 336 to 185pairs. The distributionofthe finalfigures will be evident
from Table III.
TABLIF, III.-Di8tribution of Cancer in Twin&
Monozygous.
A Total number of
Totalnumber Number Males. Females. conoordant.
twin pairs. analysed. r A- t
Total Concordant. Total Concordant. Obs. Calc. number. number.
336 185 21 2 31 5 7 5-0
Dizygous.
r -A
Same sex. Opposite sex.
A A Total number
Males. Females. Males* Females.* ofconcordant.
ol -A_
Number. Concord. Number. Concord. Number. Concord. Number. Concord. Obs. Cale.
25 1 41 2 . 27 1 40 3 7 9-2
* Sex ofprimary twin.
The observed and calculated number of twins with concordant cancer are
given. The data show that there is no significant difference between the com-TVV'IN STUDIES 161
p.uted and observed numbers. In computing the figures for expected cancers
we havepaid attention to the age distribution ofthe cancer cases, and elimination
ofthe difference in this respect between the two groups reduces the difference to
below the limits for statistical significance. There may be a tendency to a
higher cancer incidence among monozygotic twin partners of cancer patients
than among partners ofdizygotic cancerous twins, but the increase in frequency
is not statistical-ly significant.
Itmight seem natural to relate thefigures of seventwin-pairs with concordant
cancers found in each of the two groups monozveotic and dizvgotic to the total
numbers ofthemonozygotic (52) anddizygotic (133)pa'irs', in which case we come
to the conclusion that the cancer risk amongmonozygotic twinpartners of cancer
patientsis twice asheavy as the risk amongdizygotic, but such a conclusionwould
not bejustified.
If we consider the diagnoses of cancers with regard to site of the tumour in
the seven concordant cases of cancer in dizvzotic twins (Table IV), we find that
onl one shows a tumour of the same site in both partnets (Pair No. 7).
TABLE IV.-Dizygotic Twin& Both Affected.
Age and condition of-
Number. Sex. r Notified twin. Other twin.
M. 63
C.prostatae. (hist.)
2 F. 60
C. recti. (hist.)
3 F. 52
Tumour mediastini.
(hosp.)
4 F., M. 61
C. mammae, C. metast. ad
lymphonod. (hist.)
5 F.) M. 47
C. colli uteri. (hist.)
6 F., M. 81
C. recti inoperab. c.
metast.
7 M.) F. 60
C. recti. (hist.)
55
C. ventriculi operat.
(hosT
ca. 50
Tumour mammae operat.
50
C. mammae. (hist.)
58
C. solid. epithel. oris.
(hist.)
41
Carc. bronchi dx. p.m.
78
Leukosis lymphoid. Ster-
nal marrow exam.
58
C.rectiinoperabil. c. metast.
(hosp.)
" Hist." signifies histological examination.
" Hosp." signifies report from the hospital treating the twin.
When the monozygotic twins are analysed (Table V) we obtain another
impression.: No. 1, 2, 3 and 6 pairs have cancer of similar type. The first pair
is interesting in that both members have sarcomata. The second pair is a better
case than would be expected from the diagnosis
" incipient
" cancer of the first
member. The histological description of the second member does not leaveTABLEV.-Monozygotic Twins. Both Affecta.
Age and conclition of-
f- A --%
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Number.
I
Sex.
M.
r
Notified twin.
. 53
Tumour malign. dorsi c.
.metast. ad pulm.
(hosp.)
. 43
C. labii incipiens. (hist.)
. 65
C. mammae bilat. c.
metast. adcolumnam
Other twin.
52
Fibrosarcoma cutis cruris
(hist.)
31
C. labii recidivans. (hosp.)
49
C. mammae c.. metast.
(adpulm.
62
C. meatus acust. dx et cavi
tymp. c. metast. ad lym-
phonod. (hist.)
ca. 65
Gastric cancer
67
C. basocell. anguli o6uli
(hist.)
69
C. ventriculi adenomatos.
coll - (hist.)
2 . M.
3 . F.
4 . F.' . 65
C. corporis uteri. (hist.)
5 F. . 75
c. coli sigmoid.
6 F. .68
Naevocarcinoma dorsi
(hist.)
7 F. .76
C. renis sin. (urography)
" Hist." signifies histological examination.
" Hosp." signifies report from the hospitaltreating the twin.
any doubt of the malignant nature of the change. The third pair also shows
cancer of the same organ, and even if we may question whether the tumours
in pair No. 6 are homologous or not, the tendency to cancer formation in the
same site seems to be morepronounced amongmonozygotic than amongdizygotic.
twins.
Againstthearguinentthatthese numbers are veryscanty, itshouldbe stressed
that the-importance of such findings depends on the size of the material from
wh"ich they were selected-in this case 30,000 cancer patients. We must admit
that there may Ve a slight selection in favour of the accessible sites. More
information was obtained about twins with accessible than with in'accessible
cancer. It is believed that it ma%17 be due to the fact that accessible tumours,
more often than inaccessible, are treated in the radio-therapy centres, and thus
become available for analysis -in higher numbers.
SUMMARY.
(1) The material used forgeneticalinvestigation,having been collectecl during sixyears from apopulationwhich atthe same timehas been sub'ect toregistration
ofall cancer cases, is considered to be unselected.
(2) The data obtainecl inclicate a tenclency to a higher incidence of cancer
amongpartners ofmonozygotic cancerous twins than amongpartners ofdizygoticFAMILY HISTORIES IN BREAST CANCER 163
twinswith cancer,butthe deviations from the expected values arenotstatistically
significant ifthe age distribution ofthe material is taken into account. However,
there is a clear tendency for the tumours in monozygotic pairs to affect corre-
sponding organs in both partners, whereas this is not the case among dizygotic
twins.
(3) There is good reason to believe that continued examinations aloni this
line will be able to demonstrate an increased tendency to malignant diseases as
a whole among partners of monozygotic twins with cancer, but if we are to
evaluate inheritance for cancers of single site we can only hope to achieve this
by cancer registration covering a longer period.
FAMILY HISTORIES OF 459 PATIENTS WITH CANCER OF
THE BREAST.
D. W. SMITHERS.
From the Royal Cancer Hospital (Free), London, S.W. 3.
Given at the Symposium on the Genetics of Cancer, London, June 24 and 25, 1948.
SINCE 1944 we have taken a detailed family history from allpatients reporting
with carcinoma ofthe breast. We have 459 family records up to the end of 1947
which are reasonably complete. So far we have not succeeded in supplementing
these histories, taken at the time of first visit to hospital, by later questions to
the surviving patients or by arranging visits to their homes or relations. Some
attempt has been made to confirm the causes of death of relatives by letters to
hospitals, doctors and the Registrar-General's department, but such confirmation
has, as yet, been obtained in only a few cases.
Our figures, therefore, contain all those errors of inadequate information and
faulty recollection that one would expect from data collected. in this way. There
are, however, reasons for believing that they represent an under-estimate rather
than an over-estimate of the cancer incidence in these families. Many people
die of cancer without their relations knowing that this was the cause of death.
It is in fact surprising how successful a woman can be in concealing a cancer
of the breast from her nearest relatives living in the same house with her. It is
not, therefore, so surprising that more distant relatives, or even close relatives
living away from home, may be unaware of the nature of the illness involved
Relations, even some of an older generation, who are still living at the time
that the patient is first questioned may later develop malignant disease. Many
patients with cancer of the breast survive for long periods following treatment,
and may ultimately die from some other cause; we are, however, unable to
include patients living who either have, or have had, cancer in our figures for
comparisonwith expected incidence inthe general population because no adequate
morbidity statistics are available. In our series, for instance, there are the same
number of sisters alive following treatment for cancer of the breast as there are
sisters who died of the disease.' Comparisons must be made on a basis of mor-